BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 33413028)

  • 1. Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.
    Wei H; Li L; Zhang H; Xu F; Chen L; Che G; Wang Y
    Cell Cycle; 2021 Jan; 20(2):166-178. PubMed ID: 33413028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
    Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
    IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
    Yang C; Shi J; Wang J; Hao D; An J; Jiang J
    Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.
    Liu Y; Li C; Liu H; Wang J
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating
    Yu C; Ying J; Yu K; Shen W; Jiang M
    Cancer Biother Radiopharm; 2022 Mar; 37(2):73-83. PubMed ID: 32580576
    [No Abstract]   [Full Text] [Related]  

  • 7. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression.
    Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
    Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
    Zhang W; Song C; Ren X
    Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis.
    Yang F; Pei Y; Xu W; Rong L
    Dis Markers; 2022; 2022():8402116. PubMed ID: 36193508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer.
    Liu G; Shi H; Deng L; Zheng H; Kong W; Wen X; Bi H
    Biochem Biophys Res Commun; 2019 May; 513(1):207-212. PubMed ID: 30954221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol suppresses lung cancer tumorigenesis by modulating the circ-ERBB2/miR-7-5p/FOXM1 axis.
    Gao J; Ding C; Zhou J; Wu G; Han Z; Li J; Hei F
    Thorac Cancer; 2021 Mar; 12(6):824-834. PubMed ID: 33506582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0042823 accelerates cancer progression
    Wu T; Sun Y; Sun Z; Li S; Wang W; Yu B; Wang G
    Ann Med; 2021 Dec; 53(1):960-970. PubMed ID: 34124974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer.
    Ma N; Zhang W; Qiao C; Luo H; Zhang X; Liu D; Zang S; Zhang L; Bai J
    Cell Physiol Biochem; 2016; 38(4):1435-46. PubMed ID: 27035590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
    Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M
    J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0020123 promotes non-small cell lung cancer progression via miR-146a-5p mediated regulation of EIF4G2 expression.
    Wei Z; Liu J; Hui G; Luan X
    Thorac Cancer; 2024 Jan; 15(1):44-56. PubMed ID: 37993106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
    Guo C; Wang H; Jiang H; Qiao L; Wang X
    Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
    [No Abstract]   [Full Text] [Related]  

  • 20. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
    Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
    Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.